Sandoz Srbija company information, Employees & Contact Information

Sandoz reaches agreement with Regeneron, resolving all patent litigation related to its US aflibercept biosimilar Sandoz

Product Safety Notices Sandoz

Lupin joins hands with Sandoz to commercialize biosimilar Ranibizumab across multiple regions Business Standard

Swill Back Decadently Boozy Heart Of Darkness Cocktail HERE In Aerocity So City

Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France Sandoz

Sandoz CEO on navigating Trump's tariffs, "distorted" U.S. drug market Axios

Sandoz and Regeneron reach agreement over biosimilar dispute Ophthalmology Times

Sandoz bolsters in-house biosimilar manufacturing with Evotec acquisition Pharmaceutical Technology

Lupin partners with Sandoz for launch and commercialization of ranibizumab across global markets Business Standard

Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications Sandoz

Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach Sandoz

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1] Sandoz

Corporate Governance Sandoz

Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations Sandoz

Business Sandoz

Sandoz joins Energize Program to support suppliers in decarbonization efforts Sandoz

About Sandoz Sandoz

Driving impact and access Sandoz

Sandoz launches rivaroxaban in Germany, expanding access to high-quality antithrombotic treatment options Sandoz

Select strengths of Sandoz immunology biosimilar granted interchangeability by FDA Sandoz

Generics Sandoz

Sandoz signs Science Based Targets Initiative (SBTi) Commitment Letter Sandoz

Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars Sandoz

News Archive Sandoz

People and culture Sandoz

Environment Sandoz

Sandoz opens new Device Development Center in Cambridge, UK Sandoz

Sandoz celebrates the inauguration of new global headquarters in Basel Sandoz

Flexible-Hybrid Working at Sandoz Sandoz

Sandoz lifts guidance after Humira biosimilar drives another quarter of sales growth Fierce Pharma

Sandoz receives US FDA approval for biosimilar Hyrimoz® (adalimumab-adaz) high-concentration formulation Novartis

Media Sandoz

Sandoz, on a $1.1B investment spree in Slovenia, breaks ground at new $440M biosimilar plant Fierce Pharma

Sandoz enters $265 million settlement agreement in U.S. price-fixing case Reuters

Sandoz taps Evotec in long-term biosimilar development and manufacturing deal Fierce Pharma

Novartis' Sandoz dips on debut after lower than expected valuation Reuters

Novartis confirms Sandoz Spin-off for October 4, 2023 Novartis

Amid tough generics market, Sandoz to lay off 213 and shutter Eon Labs plant in North Carolina Fierce Pharma

In splitting from Novartis, Sandoz makes muted market debut Fierce Pharma

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine Novartis

South Africa's Aspen expands reach with $100M buy of Sandoz's Chinese business Fierce Pharma

Case Note: Sandoz v. Amgen Food and Drug Law Institute (FDLI)

Lupin ties up with Sandoz to commercialise biosimilar product The Economic Times

Biocon Biologics partners with Sandoz Australia to sell cancer drugs Business Standard

Sort Your Meaty Cravings With This Plate Of Creamy Butter Chicken In Lajpat So City

Biocon Biologics grants Sandoz exclusive rights to market biosimilar adalimumab in Japan The Economic Times

Aurobindo buys US units of Sandoz for $900 million The Economic Times

Sandoz gets FDA rap over documentation at plants Business Standard

Cipla gains as partner Sandoz gets USFDA approval for generic drug The Economic Times

Why You Should Visit SANDOZ In Lajpat? | So Delhi So City

Sandoz to close generic development centre Business Standard

Freedom Roost Powered By Sandoz For Alcohol Deals | So Delhi So City

The New SANDOZ Outlet In CP Is Now Open | So Delhi So City

Dine Out With Your Fam At The Incredibly Stunning SANDOZ | So Delhi So City

Aurobindo Pharma touches all-time high, soars by 9% on Sandoz deal Zee Business

Sandoz shuts unit near Mumbai Business Standard

Airoli hospital gets medical equipment worth Rs 1 crore under Sandoz company CSR Medical Buyer

Sandoz Knocks Court Doors For Fresh Swap Ratio Business Standard